Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology

Advanced search

Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support

https://doi.org/10.17749/2070-4909.2019.12.3.210-220

Full Text:

Abstract

Clinical / Economic Analysis and the common ABC / VEN analysis are currently used to estimate the qualitative and quantitative indicators of drug supply.

Materials and methods. We used the official information from the national portals www.grls.rosminzdrav.ru and http://zakupki.gov.ru, on the imported medicines and the manufacturing countries related to “The Program for Providing Essential Medicines to Certain Categories of Citizens in the Russian Federation” in two regions of the Far Eastern Federal District.

Results. In Region 1, the highest level of domestically produced drugs (68.7%) was observed in 2014; in 2014-2015 it dropped significantly to 53.8% and 54.1%, respectively. In Region 2, the similar values were 69.6% in 2014, with a trend to decrease to 66.0% in 2015, and 62.4% in 2016. The highest replacement rates were recorded for the moderate and low consumption categories – «B» and «C», and also for essential and non-essential medicines – «E» and «N».

Discussion. The import replacement in the subsidized medicine supply is a complex dynamic process. The authors suggest that the reduced replacement of the imported drugs can be explained by both objective (the actual absence of the respective Russia-made analogues) and subjective (irrational approaches to the procurement of medicines due to the lack of an appropriate algorithm). Therefore, further work is needed to rationalize and advance the priority of the domestic medicines for the subsidized segment of drug supply.

Conclusion. The study shows that the situation with the import replacement in the subsidized segment is satisfactory. However, the reduced number of domestically-produced medicines found in this study, necessitates changes in the procurement policy regarding the medicines fully manufactured in Russia. The present article proposes criteria for the assessment of import replacement and recommends measures for improving the work in this direction.

 

 

About the Authors

E. V. Eliseeva 
Federal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
MD, PhD, Professor & Head, Department of Pharmacology and Clinical Pharmacology. Vice-Rector


E. S. Maneeva 
Federal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
MD, PhD, Assistant, Department of Pharmacology and Clinical Pharmacology


R. K. Goncharova 
Federal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
MD, PhD, Associate Professor, Department of Pharmacology and Clinical Pharmacology


A. V. Kropotov
Federal State Budgetary Educational Institution of Higher Education «Pacific State Medical University» of the Ministry of Healthcare of the Russian Federation
Russian Federation
MD, PhD, Professor, Department of Pharmacology and Clinical Pharmacology


References

1. Order of the Ministry of Health of the Russian Federation of February 13, 2013 No. 66 «On Approval of the Strategy of Medicinal Provision of the population of the Russian Federation for the period up to 2025 and the plan for its implementation». URL: https://www.garant.ru/products/ ipo/prime/doc/70217532/. Accessed: 16.06.2019. (in Russ).

2. Decree of the Government of Russian Federation of December 28, 2017 No. 1673 «On Amendments to the State Programme of Russian Federation «Development of the Pharmaceutical and Medical Industry» for 2013-2020». URL: https://www.garant.ru/products/ipo/ prime/doc/71748840/. Accessed: 16.06.2019. (in Russ).

3. Gaygolnik T.V., Demko I.V., Bochanova E.N., Kraposhina A.Yu., Gordeeva N.V., Solov’eva I.A. Pharmaco-economic analysis of cost in terms of maintenance of preferential medicines patients with Chronic Obstructive Pulmonary Disease on the territory of Krasnoyarsk Region. FARMAKOEKONOMIKA. Sovremennaya Farmakoekonomika i Farmakoepidemiologiya / PHARMACOECONOMICS. Modern Pharmacoeconomics and Pharmacoepidemiology (in Russ). 2016; 2: 49-59.

4. Stakhovskaya L. V., Ivanova G. E., Repyev A. P. Medical Law and Legal Bases of Medical Rehabilitation. Pacific Medical Journal (in Russ).. 2015; 1: 30-34.

5. Dzanaeva A.V., Omel’yanovskii V. V., Kagermazova S.A. Principles of import substitution regarding drugs. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology (in Russ). 2015; 2: 38-42.

6. Resolution of the VII All-Russian Congress of Patients. FARMAKOEKONOMIKA. Sovremennaya farmakoekonomika i farmakoepidemiologiya / PHARMACOECONOMICS. Modern pharmacoeconomics and pharmacoepidemiology (in Russ). 2016; 9 (4): 54-63.

7. Grigorieva K. D. Medicinal import substitution is a promising direction for the development of the Russian economy. Management Advice (in Russ). 2018; 5: 137-142.

8. Kostromin P. A. Import substitution of medicines in Russia by volume, nomenclature and quality. Theory and Practice of Public Development (in Russ). 2015; 9: 73-77.

9. Analytical Report. Pharmaceutical Market of Russia. Results of 2014. URL: https://dsm.ru/docs/analytics/dsm_report_2014_eng_ web.pdf. Accessed: 16.06.2019. (in Russ).

10. Analytical Report. Pharmaceutical Market of Russia Results of 2015. URL: https://dsm.ru/docs/analytics/Annual_report_2015_DSM_ web.pdf. Accessed: 16.06.2019. (in Russ).

11. The Russian Pharmaceutical Market in 2016. URL: https://dsm.ru/ docs/analytics/Annual_Report_2016_rus.pdf. Accessed: 16.06.2019. (in Russ).

12. Russian Pharmaceutical Market 2017. URL: https://dsm.ru/ docs/analytics/Annual_Report_2017_rus.pdf. Accessed: 16.06.2019. (in Russ).

13. Decree of the Government of the Russian Federation No. 2724-r of December 26, 2015 «On Approval of the List of Essential Medicines for 2016, as well as Lists of Medicines for Medical Use and the Minimal Range of Medicines Required for Medical Care». Application No. 2. «The List of Medicinal Products for Medical Use, including Medicinal Products for Medical Use, Appointed by the Decision of Medical Committees of Medical Organizations». URL: http://www.consultant.ru/ document/cons_doc_LAW_192036/c29b5a70a7a807e6e-474a9d590e5667b5cb1d272/. Accessed: 16.06.2019. (in Russ).

14. Frolov M. Yu., Barkanova O. N., Shatalova O. V. Method of carrying out ABC/VEN-analysis. Medicinal Bulletin (in Russ). 2012; 6 (46): 3-6.

15. Website of Federal State Statistic Service. URL: http://www.gks. ru. Accessed: 16.06.2019. (in Russ).

16. Korobeynikova A. N., Malchikova S. V. ABC-, VEN- and frequency analysis of treatment of Atrial Fibrillation in outcome patients. FARMAKOEKONOMIKA. Sovremennaya Farmakoekonomika i Farmakoepidemiologiya / PHARMACOECONOMICS. Modern Pharmacoeconomics and Pharmacoepidemiology. 2015; 4: 28-31 (in Russ).

17. Khalafyan A. A., Koshkarov A. A., Fabritskaya E. Yu. Decision support based on ABC/VEN-analysis on Preferential Medicinal Consumption. Fundamental Research (in Russ). 2016; 4: 323-327.

18. Mundy L.M., Apisarnthanarak A. Economic Analysis in Healthcare Epidemiology. URL: https://basicmedicalkey.com/economic-analysis-in-healthcare-epidemiology/. Accessed: 12.04.2019. (in Russ).

19. Soleymani F., Abdollahi M. Management information system in promoting rational drug use. International Journal of Pharmacology (in Russ). 2012; 8(6): 586-589.

20. «State List of Medicines». URL: https://grls.rosminzdrav.ru. Accessed: 16.06.2019.

21. «United Information System of Purchases». URL: www. zakupki.gov.ru. Accessed: 16.06.2019. (in Russ).

22. Resolution of the meeting of the working group of the Russian Antiepileptic League. Epilepsia i paroksizmalʹnye sostoania / Epilepsy and Paroxysmal Conditions (in Russ). 2016; 8 (4): 109-111. https:// www.epilepsia.su/jour/article/view/324. Accessed: 16.06.2019.


For citation:


Eliseeva  E.V., Maneeva  E.S., Goncharova  R.K., Kropotov A.V. Clinical and economic analysis as an instrument for harmonizing import substitution in the preferential segment of medicinal support. FARMAKOEKONOMIKA. Modern Pharmacoeconomic and Pharmacoepidemiology. 2019;12(3):210-220. (In Russ.) https://doi.org/10.17749/2070-4909.2019.12.3.210-220

Views: 107


ISSN 2070-4909 (Print)
ISSN 2070-4933 (Online)